(+)-Naloxone

Naloxone

(+)-Naloxone is an opioid antagonist used primarily in the management of opioid overdose. It is a stereoisomer of naloxone, which is a medication used to block the effects of opioids, especially in overdose.

Chemical Structure

(+)-Naloxone is a stereoisomer of naloxone, which means it has the same chemical formula but a different spatial arrangement of atoms. The chemical formula for naloxone is C19H21NO4, and it has a molecular weight of 327.37 g/mol. The structure includes a morphinan backbone, which is characteristic of many opioid compounds.

Mechanism of Action

(+)-Naloxone works by competitively binding to the opioid receptors in the central nervous system. It has a higher affinity for the mu-opioid receptor than for the kappa-opioid receptor or delta-opioid receptor, which allows it to effectively displace opioid agonists such as morphine and heroin. This displacement reverses the effects of opioids, including respiratory depression, sedation, and hypotension.

Pharmacokinetics

Absorption

(+)-Naloxone is typically administered via intravenous, intramuscular, or subcutaneous routes. It has a rapid onset of action, especially when given intravenously, with effects typically seen within minutes.

Distribution

The drug is widely distributed throughout the body, including the brain, where it exerts its effects. It is highly protein-bound, which affects its distribution and duration of action.

Metabolism

(+)-Naloxone is primarily metabolized in the liver by glucuronidation. The major metabolite is naloxone-3-glucuronide, which is inactive.

Elimination

The elimination half-life of (+)-naloxone is approximately 1 to 1.5 hours. It is excreted primarily in the urine, both as unchanged drug and as metabolites.

Clinical Use

(+)-Naloxone is used in the emergency treatment of known or suspected opioid overdose. It is also used in the management of opioid-induced respiratory depression and in the diagnosis of suspected opioid overdose.

Adverse Effects

Common adverse effects of (+)-naloxone include nausea, vomiting, sweating, tachycardia, increased blood pressure, and tremors. In patients who are opioid-dependent, administration of naloxone can precipitate acute withdrawal symptoms.

Contraindications

There are no absolute contraindications to the use of (+)-naloxone in the setting of life-threatening opioid overdose. However, caution is advised in patients with known hypersensitivity to naloxone or any of its components.

Research and Development

Research is ongoing to explore the use of (+)-naloxone in other conditions, such as opioid-induced bowel dysfunction and as an adjunct in pain management to reduce opioid side effects.

See Also

• Naloxone
• Opioid overdose
• Opioid receptor

External Links

• DrugBank: Naloxone
• PubChem: Naloxone